Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $869,067 - $1.71 Million
13,656 Added 185.95%
21,000 $1.4 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $29.6 Million - $48.8 Million
-292,656 Reduced 97.55%
7,344 $872,000
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $25.6 Million - $34.6 Million
-300,000 Reduced 50.0%
300,000 $32 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $3.48 Million - $5.22 Million
50,000 Added 9.09%
600,000 $59.7 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $28 Million - $36.7 Million
290,000 Added 111.54%
550,000 $56.8 Million
Q2 2023

Jul 31, 2023

BUY
$118.5 - $160.53 $14.8 Million - $20.1 Million
125,000 Added 92.59%
260,000 $31.6 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $678,300 - $985,100
-5,000 Reduced 3.57%
135,000 $20.7 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $1.68 Million - $2.98 Million
-14,200 Reduced 9.21%
140,000 $25.1 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $2.95 Million - $4.85 Million
-25,000 Reduced 13.95%
154,200 $18.2 Million
Q2 2022

Aug 08, 2022

BUY
$117.13 - $176.59 $445,094 - $671,042
3,800 Added 2.17%
179,200 $25.6 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $17.2 Million - $32.1 Million
136,400 Added 349.74%
175,400 $30.2 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $8.81 Million - $14.4 Million
39,000 New
39,000 $9.91 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.